Evidence map›Paper›PMID 33553393›Full record

ArticleWorld journal of clinical cases2021

Role of ammonia in predicting the outcome of patients with acute-on-chronic liver failure.

Stefan Chiriac, Carol Stanciu, Camelia Cojocariu, Ana-Maria Singeap, Catalin Sfarti, Tudor Cuciureanu, Irina Girleanu, Razvan Alexandru Igna, Anca Trifan

Open access · diamondAbstract read
In one paragraph

Article in World journal of clinical cases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. The Story of Ammonia in Liver Disease: An Unraveling Continuum.Journal of clinical and experimental hepatology
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Stefan ChiriacDepartment of Gastroenterology, "Grigore T. Popa" University of Medicine and Pharmacy, Iasi 700115, Romania.
Carol StanciuInstitute of Gastroenterology and Hepatology, "St. Spiridon" Emergency Hospital, Iasi 700111, Romania.
Camelia CojocariuDepartment of Gastroenterology, "Grigore T. Popa" University of Medicine and Pharmacy, Iasi 700115, Romania.
Ana-Maria SingeapDepartment of Gastroenterology, "Grigore T. Popa" University of Medicine and Pharmacy, Iasi 700115, Romania.
Catalin SfartiDepartment of Gastroenterology, "Grigore T. Popa" University of Medicine and Pharmacy, Iasi 700115, Romania.
Tudor CuciureanuDepartment of Gastroenterology, "Grigore T. Popa" University of Medicine and Pharmacy, Iasi 700115, Romania.
Irina GirleanuDepartment of Gastroenterology, "Grigore T. Popa" University of Medicine and Pharmacy, Iasi 700115, Romania.
Razvan Alexandru IgnaIntensive Care, "Grigore T. Popa" University of Medicine and Pharmacy, Iasi 700115, Romania.
Anca TrifanDepartment of Gastroenterology, "Grigore T. Popa" University of Medicine and Pharmacy, Iasi 700115, Romania.
Grigore T. Popa University of Medicine and Pharmacy · ROSpitalul Clinic Judeţean de Urgenţe "Sf. Spiridon" Iaşi · RO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHigh venous ammonia (VA) values have been proven to be a part of the mechanism of hepatic encephalopathy in patients with liver cirrhosis (LC) as well as acute hepatitis. Moreover, VA has been associated with poor prognosis and high mortality in these clinical settings. However, the role of ammonia in acute-on-chronic liver failure (ACLF) has not yet been clearly established.

aimTo assess the role of VA in predicting the outcome of cirrhotic patients with ACLF in a tertiary care center.

methodsWe performed a retrospective observational study including consecutive patients with LC hospitalized for acute non-elective indications such as ascites, hepatic encephalopathy (HE), upper gastrointestinal bleeding, or bacterial infections that fulfilled the Asian Pacific Association for the Study of the Liver (APASL) criteria for ACLF. The study was conducted in "St. Spiridon" University Hospital, Iasi, Romania, a tertiary care center, between January 2017 and January 2019. The APASL ACLF Research Consortium (AARC) score was calculated and ACLF grade was established accordingly. West-haven classification was used for HE. Statistical analysis was performed using IBM SPSS version 22.0.

resultsFour hundred and forty-six patients were included, aged 59 (50-65) years, 57.4% men. Child-Pugh, model for end-stage liver disease (MELD) and AARC scores were 11 (10-12), 19.13 ± 6.79, and 7 (6-8), respectively. 66.4% had ACLF grade I, 31.2% ACLF grade II, and 2.5% ACLF grade III. HE was diagnosed in 83.9%, 34% grade I, 37.2% grade II, 23.5% grade III, and 5.3% grade IV. Overall mortality was 7.8%. VA was 103 (78-148) μmol/L. Receiver operating characteristic analysis showed good accuracy for the prediction of in-hospital mortality for the AARC score [Area under the curve (AUC) = 0.886], MELD score (AUC = 0.816), VA (AUC = 0.812) and a fair accuracy for the Child-Pugh score (AUC = 0.799). Subsequently, a cut-off value for the prediction of mortality was identified for VA (152.5 μmol/L, sensitivity = 0.706, 1-specificity = 0.190). Univariate analysis found acute kidney injury, severe HE (grade III or IV), VA ≥ 152.5 μmol/L, MELD score ≥ 22.5, Child-Pugh score ≥ 12.5, and AARC score ≥ 8.5 to be associated with in-hospital mortality. Multivariate analysis identified AARC score ≥ 8.5 and venous ammonia ≥ 152 μmol/L to be independent predictors of in-hospital mortality.

conclusionVA could be used as an inexpensive predictor of in-hospital mortality in patients with ACLF. Patients with both ACLF and VA > 152.5 μmol/L have a high risk for a poor outcome.

Indexed as

Acute-on-chronic liver failureAsian Pacific Association for the Study of the Liver Acute-on-chronic Liver Failure Research Consortium scoreCirrhosisHepatic encephalopathyMortalityVenous ammonia

Identifiers

PMID33553393
PMCPMC7829715
OpenAlexW3124412921

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.